Delivery Order SPE2DB22D3016-SPE2DB25FBFH4
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,329.44 by the Defense Logistics Agency (DLA) for the supply of Imdelltra 10 mg vials. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 2, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, designated as SPE2DX and valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,129.52 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025. This firm fixed-price delivery order, which has an ultimate completion date of August 4, 2025, was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,207.80 on August 16, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by August 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,637.82 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is set for ultimate completion on August 12, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,135.25 on August 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 19, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,900.76 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025, with an ultimate completion date of August 4, 2025. This contract, issued under a firm fixed-price arrangement with no set-aside designation, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $16,241.52 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,325.67 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The award was made through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,839.02 on July 20, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price contract, issued through the Defense Logistics Agency's Medical Supply Chain, represents a competitively awarded, non-set-aside procurement. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,781.18 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFH4Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,897.75 from the Defense Logistics Agency on August 18, 2025, for Imkeldi 80 mg/ml solution (140 ml). The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and was awarded through competitive procurement with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The DLA Troop Support Medical IDC enables the company to furnish specialty medications, brand-name and generic drugs, vaccines, and specialized medical commodities to support Defense Health Agency operations and other government healthcare systems worldwide. This delivery order for Imkeldi, a prescription medication, represents a routine fulfillment under the company's established framework agreement with DLA to supply pharmaceutical products essential for military medical readiness and patient care requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/18/25 |